KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Research & Development (2020 - 2025)

Organon (OGN) has 6 years of Research & Development data on record, last reported at $91.0 million in Q4 2025.

  • For Q4 2025, Research & Development fell 30.0% year-over-year to $91.0 million; the TTM value through Dec 2025 reached $366.0 million, down 27.67%, while the annual FY2025 figure was $366.0 million, 21.96% down from the prior year.
  • Research & Development reached $91.0 million in Q4 2025 per OGN's latest filing, up from $84.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $170.0 million in Q1 2024 and bottomed at $67.0 million in Q1 2021.
  • Average Research & Development over 5 years is $111.8 million, with a median of $110.5 million recorded in 2021.
  • Peak YoY movement for Research & Development: skyrocketed 105.56% in 2021, then tumbled 43.53% in 2025.
  • A 5-year view of Research & Development shows it stood at $110.0 million in 2021, then grew by 29.09% to $142.0 million in 2022, then dropped by 5.63% to $134.0 million in 2023, then decreased by 2.99% to $130.0 million in 2024, then dropped by 30.0% to $91.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $91.0 million in Q4 2025, $84.0 million in Q3 2025, and $95.0 million in Q2 2025.